CTGCT
  • en
    • si
  • About us
    • Partners
    • Publications
  • Job Openings
  • Products and Services
  • Learning Box
  • POSTS
    • Events
    • Articles
    • News
  • Get in touch

Articles

  • Articles
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • Raziskave
  • CTGCT
  • NIC
  • Rodrigo Ortiz
8 April 2025 Event Date: 21 March 2025 do: 21 March 2025 •

CTGCT’s Role in the GeneH Project: Accelerating Gene Therapy Innovations

We are thrilled to announce our participation in the GeneH consortium, an ambitious project led by the University of Coimbra, and their GeneT project, colead by the Kemijski Inštitut with the CTGCT project, aimed ...

  • Articles
  • Clinicians
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Manufacturing Process
  • Regulation
  • CTGCT
  • UMCUtrecht
  • Rodrigo Ortiz
5 March 2025

Navigating Viral Vector Production for Gene Therapy

This week we had the opportunity to listen to Ganesh Ramesh, a PhD candidate at the Viral Vector Production Center for Translation Immunology of UMC Utrecht, under the supervision of Dr. Zsolt Sebestyen. Here ...

Ctgct Scientific Talk March 2025
  • Articles
  • Pacients
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Economics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 February 2025

How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome

Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ...

Paving The Way Ctnnb1
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
25 February 2025

Controlling Cells With Chemically Switchable Antibodies: A New Opportunity For Precision Therapy

Imagine being able to turn a cell’s behavior ON or OFF, just like flipping a light switch. That’s exactly what scientists have achieved with the innovative technology presented in this paper published in the ...

Graphical Abstract Controlling Cells
  • Articles
  • Pacients
  • CTGCT
  • Gregor Cuzak
18 February 2025

Hugs for rare

The 28th of February is approaching which is the Day of Rare diseases. Hugs are being collected in 7 countries to raise awareness of the importance of everyone working together to defeat rare diseases.

Hugs1
  • Articles
  • Pacients
  • Research
  • CTGCT
11 February 2025

Women at CTGCT: Voices from the Lab

Today we we celebrate the International Day of Women and Girls in Science, we take a moment to spotlight the women working at the Centre for the Technologies of Gene and Cell Therapy (CTGCT)

Women In Science Cover, image generated using AI, Dall-e
  • Articles
  • Pacients
  • Researchers
  • Gen Therapy
  • Laboratory
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 January 2025

The research on combining cytokines with pyroptosis is gaining widespread media coverage

Research on combining cytokines and pyroptosis for cancer therapy by Slovenian scientists has gained significant media recognition, including TV features, articles, and the honor of being named "Names of the Week".

Odmevi Sara N Iva
  • Articles
  • Clinicians
  • Pacients
  • Cell therapy
  • Gen Therapy
  • Laboratory
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
7 January 2025

Combining cytokines and pyroptosis, a promising weapon against cancer

A recent study published in Nature Communications has unveiled a groundbreaking approach that combines the power of cytokines with a type of cell death called pyroptosis to boost the immune system's ability to fight ...

Cytokine Pyroptosis
  • Articles
  • Media Releases
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Research
  • Charite Berlin
  • CTGCT
  • NIC
  • TUD
  • UCL
  • UMCUtrecht
  • Rodrigo Ortiz
6 December 2024

CTGCT’s Innovation Report on Gene and Cell Therapy

We are pleased to share that our latest paper has been accepted for publication in the Computational and Structural Biotechnology Journal (CSBJ)

Innovation Report Abstract
  • Articles
  • Pacients
  • Gen Therapy
  • Drug Discovery
  • Laboratory
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
22 November 2024

MyD88 balances cell homeostasis by regulating immune response, mitochondrial function and cell death

A recent study by researchers in the CTGCT investigates the role of the MyD88 protein, a key player in innate immune signaling pathways.

Myd88 Blogpost Cover
  • Articles
  • Clinicians
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • GLP
  • GMP
  • Manufacturing Process
  • Pre Clinical
  • Regulation
  • UCL
  • Rodrigo Ortiz
4 November 2024

Transforming Advanced Therapy Manufacturing: The Braintree Innovation Centre

case study on the Braintree Manufacturing Innovation Centre (Braintree MIC), recently licensed by the MHRA. This state-of-the-art facility is revolutionizing the field of advanced therapy medicinal products (ATMPs) by providing cutting-edge infrastructure and expertise ...

Braintree Mic
  • Articles
  • Pacients
  • Researchers
  • Cell therapy
  • Gen Therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
30 August 2024

Exciting news in Sonogenetics: A New Frontier for Deep Tissue Treatment

Researchers have made a discovery that could change how we treat some diseases deep within the human body. This technique, known as sonogenetics, combines the power of ultrasound with genetically engineered cells to deliver ...

Graphical Abstract Sonogenetics

Posts pagination

1 2

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ministry Logo

 

Project: 101059842 – CTGCT – HORIZON-WIDERA-2022

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them


CTGCT © 2025
Website production: Kreativna tovarna